EBM

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Delaney, B.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Delaney, B.
Evidence-Based Medicine 2003; 8:21
© 2003 BMJ Publishing Group


Therapeutics

Helicobacter pylori eradication improved dyspepsia symptoms

Chiba N, Veldhuyzen van Zanten SJ, Sinclair P, et al.Treating Helicobacter pylori infection in primary care patients with uninvestigated dyspepsia: the Canadian adult dyspepsia empiric treatment—Helicobacter pylori positive (CADET-Hp) randomised controlled trial. BMJ 2002;324:1012–6.[Abstract/Free Full Text]

QUESTION: In patients with dyspepsia and a positive test result for Helicobacter pylori, is an H pylori eradication strategy more effective than placebo for improving dyspepsia symptoms?

Key Words: dyspepsia • Helicobacter pylori

The first 150 words of the full text of this article appear below.

Design
Randomised {allocation concealed*}{dagger}, blinded (clinicians, patients, data collectors, outcome assessors, {data analysts, and manuscript writers}{dagger}),* placebo controlled trial with 1 year of follow up.

Setting
36 family practices in Canada.

Patients
294 patients (mean age 49 y, 50% men) who were >=18 years of age and had uninvestigated symptoms of dyspepsia for >=3 months. Dyspepsia was defined as a complex of epigastric pain including heartburn, acid regurgitation, excessive burping or belching, increased abdominal bloating, nausea, abnormal or slow digestion, or early satiety. All patients had to have positive test results for H pylori on the Helisal rapid blood test and the 13C-urea breath test. Exclusion criteria included gastrooesophageal reflux disease, upper gastrointestinal investigation in the previous 6 months or >=2 times in the past 10 years, eradication therapy for H pylori in the past 6 months, previous gastric surgery, ulcer disease or endoscopic oesophagitis, and irritable bowel syndrome. Follow . . . [Full text of this article]

Brendan Delaney, MD, FRCP, MRCGP

University of Birmingham
Birmingham, UK







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2003 by the BMJ Publishing Group Ltd.